Andrew Firlik

ANDREW FIRLIK MANAGING PARTNER

Andrew brings to JAZZ significant experience in venture capital, company building, technology development, and neurosurgery. He has served as founder, investor, director, and chairman of many successful companies. Prior to joining the firm, he was a general partner at Flare Capital. Previously, he was a venture partner at Sprout Group and a principal at Canaan Partners. Andrew has led numerous venture capital investments and has helped many early stage companies become market leaders. He was a founder (and invented the core technology) of Northstar Neuroscience, which went public in 2006 (NASDAQ: NSTR) and was subsequently acquired by St. Jude Medical (NYSE: STJ). He also served as Chairman of IntElect Medical, which was acquired by Boston Scientific (NYSE: BSX). He currently serves as chairman of Functional Neuromodulation, a company developing brain stimulation therapy for Alzheimer’s disease. Representative prior investments and board roles include BridgePoint Medical (acquired by Boston Scientific, NYSE: BSX), Explorys (acquired by IBM, NYSE: IBM), Functional Neuromodulation, Halo Neuroscience, i1 Biometrics, Predilytics (acquired by Welltok), SetPoint Medical, Spine Wave, Vertos Medical, and Visiogen (acquired by Abbott, NYSE: ABT). During more than a decade in the healthcare profession as a neurosurgeon, he published more than 50 medical articles, wrote chapters for several medical textbooks, and was co-editor of a book about cerebrovascular surgery. His scientific work has been presented at many international conferences and he holds numerous patents for his inventions. As a board certified neurosurgeon, he served as clinical assistant professor of neurosurgery at the New York University School of Medicine. He currently serves on the Cornell Biomedical Engineering Advisory Council, the Advisory Council of the McGovern Center for Venture Development in Life Sciences at Cornell, and the Executive Board of the Yale Center for Biomedical and Interventional Technology. He has served on the Cornell University Council as chairman of the Technology Transfer Committee and member of the Life Sciences Advisory Board. He has also served as a member of the Innovation Advisory Board at the Cleveland Clinic. Andrew earned his M.D. from Weill Cornell University Medical College and his M.B.A. from the University of Pittsburgh after studying neuroscience at Cornell (A.B.) and Oxford University.

Team

Andrew Firlik, Partner

John F. Harris, Partner

Zack Lynch, Partner

John Spinale, Partner

Adam Gazzaley, Chief Scientist

Continue reading

Adam Gazzaley

ADAM GAZZALEY, M.D., PH.D. CHIEF SCIENTIST

Adam is Gazzaley Lab Director and Professor of Neurology, Physiology and Psychiatry at University of California, San Francisco. He was born and raised in New York City. He was interested in science since childhood and was always convinced that it was his career path. However, he did not discover his passion for the brain until later in his undergraduate years. He went on to receive his M.D. and Ph.D degree in Neuroscience through the NIH-sponsored Medical Scientist Training Program at the Mount Sinai School of Medicine in New York. His doctoral research, under the mentorship of Dr. John Morrison, focused on plasticity of glutamate receptors in the hippocampus and implications for cognitive changes in normal aging. This research earned him the prestigious 1997 Krieg Cortical Scholar Award. He then completed an internship in internal medicine and residency in neurology at the University of Pennsylvania. Following residency, Dr. Gazzaley traveled to UC Berkeley for a research fellowship with Dr. Mark D’Esposito and Dr. Robert Knight. The research involved studying memory and attention in humans and the changes that occur with normal aging using functional MRI and EEG. During that time period he also completed a clinical fellowship in cognitive neurology at the Memory and Aging Center under the direction of Dr. Bruce Miller and became board-certified in neurology. Dr. Adam Gazzaley obtained an M.D. and a Ph.D. in Neuroscience at the Mount Sinai School of Medicine in New York, completed clinical residency in Neurology at the University of Pennsylvania, and postdoctoral training in cognitive neuroscience at UC Berkeley. He is the founding director of the Neuroscience Imaging Center at the UC San Francisco, an Associate Professor in Neurology, Physiology and Psychiatry, and Principal Investigator of a cognitive neuroscience laboratory. His laboratory studies neural mechanisms of perception, attention and memory, with an emphasis on the impact of distraction and multitasking on these abilities. His unique research approach utilizes a powerful combination of human neurophysiological tools, including functional magnetic resonance imaging (fMRI), electroencephalography (EEG) and transcranial stimulation (TES). A major accomplishment of his research has been to expand our understanding of alterations in the aging brain that lead to cognitive decline. His most recent studies explore how we may enhance our cognitive abilities via engagement with custom designed video games, neurofeedback and TES. Dr. Gazzaley has authored over 100 scientific articles, delivered almost 400 invited presentations around the world, and his research and perspectives have been consistently profiled in high-impact media, such as The New York Times, New Yorker, Wall Street Journal, TIME, Discover, Wired, PBS, NPR, CNN and NBC Nightly News. Recently, he wrote and hosted the nationally televised, PBS-sponsored special “The Distracted Mind with Dr. Adam Gazzaley”. Awards and honors for his research include the Pfizer/AFAR Innovations in Aging Award, the Ellison Foundation New Scholar Award in Aging, and the Harold Brenner Pepinsky Early Career Award in Neurobehavioral Science. Dr. Gazzaley has won a number of awards throughout his career, including the Krieg Cortical Scholar Award (1997), Morris Bender Award in Clinical Neurology (1998),Laird Cermak Award (2005), Pfizer/AFAR Innovations in Aging Award (2005), Ellison Foundation New Scholar Award in Aging (2006), and Harold Brenner Pepinsky Early Career Award in Neurobehavioral Science (2012).

Team

Andrew Firlik, Partner

John F. Harris, Partner

Zack Lynch, Partner

John Spinale, Partner

Adam Gazzaley, Chief Scientist

Continue reading

John F. Harris

JOHN F. HARRIS MANAGING PARTNER

John is a seasoned investor, operating executive and corporate director and brings to JAZZ significant experience founding, funding and developing early-stage life sciences and technology companies. He has served as a founder, executive, corporate director, and investor to numerous companies, and has held executive in residence positions at Mayfield Fund and Versant Ventures and an Advisory Board position with Arboretum Ventures. Prior to JAZZ, John was the founder, President and CEO of NeuroVista, a Seattle-based medical device company pioneering new technologies for the management and treatment of epilepsy. NeuroVista was acquired by Cyberonics in 2013 (NASDAQ: CYBX). John was also a founder and the Vice President of Marketing and Business Development at Northstar Neuroscience, which went public in 2006 (NASDAQ: NSTR) and was subsequently acquired by St. Jude Medical (NYSE: STJ). Prior to founding Northstar, he was a founder of Heartstream, a company that revolutionized the treatment of sudden cardiac arrest with uniquely designed external defibrillators that remain the market leader and can be found in airports, airplanes, stadiums, public buildings and many other locations. Heartstream went public in 1996, was subsequently acquired by Hewlett-Packard (NYSE: HPQ). John is also a cofounder of ClearFlow, MDI Partners, and VenX, and has held board positions with Setpoint Medical, Mirador Biomedical, ExoLabs and Norfil Manufacturing. John holds a BS in industrial engineering from Stanford University and an MBA from Northwestern University’s Kellogg School of Management.

Team

Andrew Firlik, Partner

John F. Harris, Partner

Zack Lynch, Partner

John Spinale, Partner

Adam Gazzaley, Chief Scientist

Continue reading

John Spinale

JOHN SPINALE MANAGING PARTNER

John brings a deep understanding of creating innovative consumer experiences, building brands and leveraging new and emerging platforms to JAZZ. He is a proven leader in consumer technology and digital media with a career spanning nearly 20 years of building, scaling and running high-growth companies of all sizes, from initial seed through to late stage operation. He currently is an investor and active advisor to many early-stage companies, in areas ranging from virtual reality (VR) platforms and content publishers to digital health apps for diagnosing and treating cognitive conditions like ADHD. John was most recently the General Manager of Disney’s (DIS) mobile and social games division, where he launched many chart topping titles while handling the full P&L for this multi-hundred million dollar business. He has built and scaled several platforms including the first cloud-based streaming games and media company, OnLive, backed by AT&T and British Telecom, where he built the award-winning product side of the business as well as the entire content ecosystem, forging strong relationships with hundreds of media and entertainment companies.  He founded and ran the leading company in the mobile application development and messaging space, Bitmo, which he sold in 2002. He has also been involved in several restructurings and turnarounds, playing a key role in the re-launching of Activision (ATVI) from bankruptcy through to huge commercial success, as well as the restructuring and sale of the leading European game publisher Eidos (EIDSY). The products that he and his teams have built have touched hundreds of millions of consumers across the globe.  He holds a degree in Engineering from Yale.

Team

Andrew Firlik, Partner

John F. Harris, Partner

Zack Lynch, Partner

John Spinale, Partner

Adam Gazzaley, Chief Scientist

Continue reading

Zack Lynch

ZACK LYNCH MANAGING PARTNER

Zack Lynch is an entrepreneur, market maven and futurist who brings a rich understanding of the technologies and companies driving the experiential technology market to JAZZ. Zack is the founder and Chairman of the Neurotechnology Industry Organization, a global trade association representing companies involved in neuroscience, brain research institutes and patient advocacy groups, which has more than 120 member organizations all focused on accelerating the development of treatments for neurological diseases, psychiatric illnesses and nervous system injuries.He is the founder and curator of the Experiential Technology and NeuroGaming Conference and Expo which is the leading meeting bringing together game designers, neuroscientists, tech executives and investors. Zack is the author of the best selling book, The Neuro Revolution: How Brain Science Is Changing our World published by St. Martin’s Press and translated into many languages. Previously, he co-founded NeuroInsights, a market research and investment advisory firm that advises global organizations on the impact of neurotechnology on business, government and society.  NeuroInsights hosts an annual Neurotech Investing and Partnering Conference each May. He was the publisher of the investment newsletter, Neurotech Insights and co-author of NeuroInsights 600-page annual investment analysis of the global neurotech industry. He also developed the NASDAQ NeuroInsights Neurotech Index, a stock tracking index for neuroscience companies. He has been a founder and executive at several software companies in wellness, profit optimization, knowledge management and collaborative forecasting. Mr. Lynch speaks frequently and is quoted widely in the press including: Forbes, LA Times, O the Oprah Magazine, San Francisco Chronicle, Scientific American, Science, Slate and many more. Mr. Lynch serves on the advisory boards of the McGovern Institute for Brain Research at MIT, Center for Neuroeconomic Studies at Claremont Graduate University, the Center for Neuroscience and Society at the University of Pennsylvania, as well as several private neurosoftware companies. He has a B.S. in Evolutionary Biology, B.S. in Environmental Science and M.A. in Economic Geography, all from UCLA.

Team

Andrew Firlik, Partner

John F. Harris, Partner

Zack Lynch, Partner

John Spinale, Partner

Adam Gazzaley, Chief Scientist

Continue reading

JAZZ Venture Partners

©2019 JAZZ Venture Partners